When drugs are taken off the market because they are either unsafe or don’t work, do pharma companies admit that there are problems? Or do they deny the evidence?
Academic rigor, journalistic flair
Articles on Drug safety
Displaying 1 - 20 of 26 articles
It is important that herbal medicine be checked for its safety, its potential to treat particular ailments, and to ascertain its chemical components.
COVID-19 has exacerbated a backlog of domestic and foreign drug manufacturing inspections that the FDA is still too short-staffed to adequately deal with.
Vaccine manufacturing is complex, with lots of potential points for errors. But it also has extensive quality control checks and approvals.
The FDA recalled commonly used heartburn and ulcer medication ranitidine in April 2020. But new research suggests less reason for alarm.
Health Canada devotes far more resources to getting new drugs onto the market compared to making sure that drugs already being sold are safe.
Will a vaccine for COVID-19 be safe? Animal testing, human clinical trials and post-approval surveillance give us good grounds to believe that a future approved vaccine will work and be safe.
The idea that we can sit down calmly and rationally and explain to our children how they can take drugs safely overlooks a bundle of emotional issues.
There are many ways to reduce harm from drugs at music festivals beyond the much publicised pill testing. Here’s what else we can do.
Deliberately infecting people with a disease-causing agent as part of carefully considered medical research can be ethically acceptable or even necessary.
A new book, ‘The Thalidomide Catastrophe,’ raises new questions about the conduct of corporations involved. It is the duty of governments to find out the answers.
The FDA recently issued a draft guidance for testing drugs in pregnant women. Here’s why it’s a good thing.
There’s a common, popular and well-studied method to ensure new technologies are safe and effective for public use – even if researchers don’t fully understand how they work.
Health Canada proposes to increase fees to the pharmaceutical industry for prescription drug approval. This will compromise drug safety and is a risk to the health of the Canadian public.
A panel of experts has ruled that Primodos did not cause birth defects. But what’s the science behind their decision?
By exploiting the way yeast cells mate, researchers have figured out a quicker, easier way to identify on- and off-target drug interactions.
Recent reports of dangerous side effects and even early death from heartburn medications have led some to question whether this is the right medication for them.
It’s easy to overdose on the recreational drug GHB, as recent cases in Melbourne show.
An important new study in the United States has found doctors who receive just one cheap meal from a drug company tend to prescribe a lot more of that company’s products.
The view of many doctors that “I don’t let myself be influenced” might be the biggest barrier to change.
Top contributors
-
Professor Emeritus of Health Policy and Management, York University, Canada
-
Professor of Pharmacy Practice, University of Connecticut
-
Associate Professor of Comparative Effectiveness and Outcomes Research, University of Connecticut
-
Assistant Professor, Bond University
-
Vice Chancellor’s Senior Research Fellow, Social and Global Studies Centre and Digital Ethnography Research Centre, RMIT University
-
Professor at the National Drug Research Institute (Melbourne), Curtin University
-
Emeritus Professor of Clinical Sciences, University of Bristol
-
Reader in Clinical Pharmacology and Medical Education, Queen Mary University of London
-
Research Fellow in African Studies, The University of Edinburgh
-
Associate professor and Royal Society Research Fellow, Department of Psychiatry, University of Oxford
-
Associate Professor and clinical academic gastroenterologist, Western Sydney University
-
Associate Professor of History, University of Wollongong
-
Professor in Developmental Biology, University of Aberdeen
-
Professor of Bioethics, Monash Bioethics Centre, Monash University, Monash University
-
Infectious Disease Ethics Fellow, Ethox & Wellcome Centre for Ethics and Humanities, Univeristy of Oxford. Adjunct, Monash University
